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a b s t r a c t
In the present study we assessed the potential of human outgrowth endothelial cells (OEC), a subpopu-
lation within endothelial progenitor cell cultures, to support the vascularization of a complex tissue
engineered construct for bone. OEC cultured on starch polycaprolactone fiber meshes (SPCL) in mono-
culture retained their endothelial functionality and responded to angiogenic stimulation by VEGF
(vascular endothelial growth factor) in fibrin gel-assays in vitro. Co-culture of OEC with human primary
osteoblasts (pOB) on SPCL, induced an angiogenic activation of OEC towards microvessel-like structures
achieved without additional supplementation with angiogenic growth factors. Effects of co-cultures with
pOB on the vascularization process by OEC in vivo were tested by subcutaneous implantation of
Matrigel! plugs containing both, OEC and pOB, and resulted in OEC-derived blood vessels integrated into
the host tissue and anastomosed to the vascular supply. In addition, morphometric analysis of the
vascularization process by OEC indicated a better performance of OEC in the co-cultures with primary
osteoblasts compared to monocultures of OEC. The contribution of OEC to vascular structures and the
beneficial effect of the co-culture with primary human osteoblasts on the vascularization in vivo was
additionally proven by subcutaneous implantation of pre-cellularized and pre-cultured SPCL constructs.
OEC contributed to the vascular structures, by generating autogenic vessels or by incorporation into
chimeric vessels consisting of both, human and mouse endothelial cells. The current data highlight the
vasculogenic potential of OEC for bone tissue engineering applications and indicate a beneficial influence
of constructs including both osteoblasts and endothelial cells for vascularization strategies.
" 2008 Elsevier Ltd. All rights reserved.
1. Introduction
Therapeutic success in tissue engineering and regenerative
medicine is highly dependent on an appropriate vascularization of
the bioengineered tissue. In this context, different strategies have
been developed, including delivery systems for angiogenic growth
factors embedded in the biomaterials, as well as the generation of
prevascularized tissues by incorporation of endothelial cells. The
latter might facilitate an anastomosis of bioengineered vascular
structures with those in the peri-implant tissue, as has been
recently shown in a prevascularized tissue engineered construct for
muscle [1]. From several studies we have learned that a variety of
cell types such as fibroblasts [2], smoothmuscle cells [3] adipocytes
[4] or osteoblasts [5,6] etc. can support the generation of pre-
vascular structures by mechanisms which are currently under
further investigation. The cellular cross talk between endothelial
cells and other cell types comprises paracrine mechanisms based
on several growth factors such as VEGF and PDGF [7], as well as
direct cell to cell communication [7,8]. These molecular and cellular
processes seem to control the formation of vascular structures in
a close relation to the physiological conditions such as hypoxia [9].
Beyond the research interest in the molecular and cellular regu-
lation of angiogenesis and vasculogenesis, the concept of co-cultures
has also influenced research directed towards new therapeutic
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approaches for critical bone defects in tissue engineering. Recent
findings regarding the mutual information exchange between oste-
oblasts and endothelial cells or their corresponding precursors,
respectively, have led to marked interest in the generation of more
complex and appropriately vascularized tissue engineered products
for bone tissue [10–13].
Nevertheless, for such ‘‘pre-endothelialized’’ or ‘‘prevascular-
ized’’ tissue constructs autologous cell sources are an important
prerequisite, before they may be considered for a clinical applica-
tion. Therefore, endothelial progenitor cells become of interest as
a potential autologous cell source for endothelial cells. In particular,
one subpopulation within EPC, so called outgrowth endothelial
cells (OEC) or late endothelial progenitor cells [14–16] with endo-
thelial characteristics with respect to phenotype, as well as on the
functional level, seem to meet the requirements for a therapeutic
application. OEC can be isolated from the peripheral blood as an
easily obtainable source from an adult patient. Furthermore, OECs
are a homogenous and distinct population of cells revealing the
potential for in vitro expansion as well as a stable endothelial
phenotype [17]. Furthermore, OEC contribute to the neo-
vascularization after implantation in vivo [16,18]. Nevertheless, in
vivo studies also revealed that stabilizing cells such as smooth
muscle cells are needed to stabilize vascular structures formed in
long term in vivo experiments [19].
In our previous in vitro studies OEC formed prevascular
structures with a vascular lumen in co-culture with osteoblastic
cells lines or primary osteoblasts, indicating a beneficial effect of
this co-culture technique on the angiogenic activation of OEC [6].
Nevertheless, in bone tissue engineering biomaterials are used to
fill bone defects to ensure mechanical stability and serve as scaf-
folding material for the regenerating tissue and therapeutical cells.
In previous studies fiber mesh scaffolds generated from a blend of
starch with polycaprolactone (SPCL) have been shown to support
both endothelial cells [20] and growth of bonemarrow cells [21,22].
In the present study, we evaluated the in vitro biofunctionality of
OEC on SPCL fiber meshes in terms of their endothelial phenotype,
as well as the angiogenic activation in response to angiogenic
stimuli in vitro. In addition, we generated more complex cellular
constructs based on SPCL fiber meshes consisting of both human
OEC and primary human osteoblast in a co-culture system. Finally,
we assessed the formation of vascular structures by OEC in vivo and
the impact of co-cultures with pOB on the vascularization process
in subcutaneous implantation models based on Matrigel! plugs
and complex SPCL-based constructs.
2. Materials and methods
2.1. Isolation of human outgrowth endothelial cells
Outgrowth endothelial cells (OEC) were isolated according to previous pub-
lished protocols [6,17,23]. In brief, mononuclear cells were isolated from human
peripheral blood buffy coats by ficoll- (Sigma–Aldrich, Steinbach, Germany) gradient
centrifugation and cultured in EGM-2 (endothelial cell growth medium-2, CC-3162,
Lonza, Verviers, Belgium). Culture medium was supplemented with the kit ingre-
dients, 5% fetal calf serum (FCS, GIBCO Life Technologies, Karlsruhe, Germany) and
1% Pen/Strep. 5"106 cells/well were seeded on a 24 culture-well plate coated with
collagen (BD Europe, Heidelberg, Germany). Colonies of outgrowth endothelial cells
with endothelial morphology appearing after 3–4 weeks were trypsinized and
expanded during several passages in a splitting ratio 1:2 or 1:3. The purity and
homogeneity of OEC (about 95%) was determined by flow cytometry. HUVEC which
were used as controls were isolated and cultured as previous described.
2.2. Culture of human osteoblasts
Endosteal cancellous bone fragments from hip or knee were derived from 4
female or male patients (age 60–81) undergoing orthopaedic and trauma surgery,
who had given their consent for material use. Investigations were approved by the
local ethical committee. Primary osteoblasts were isolated and cultured according to
an outgrowth protocol as previously described [24]. In brief, bone fragments were
minced and rinsed in PBS (phosphate buffered saline) for several times followed
digestion of the bone tissue by collagenase (Type IV C-5138, Sigma, Deisenhofen,
Germany) for one hour at 37 #C. After this digestion step, bone fragments were
rinsed again with PBS for several times. Bone fragments were incubated in DMEM/
Hams F12 (GIBCO) including 20% FCS and 1% Pen/Strep to allow the outgrowth of the
cells from the bone fragments. Confluent cultures were passaged using acutase
(PAA) in a ratio of 1:3 and further cultured in DMEM/Hams F12 supplemented with
10% FCS. For the present studies cells passage 1 to passage 4 were used to generate
co-cultures.
2.3. Generation of SPCL constructs
SPCL scaffolds were generated and sterilized as previously described [22]. Prior
to cell seeding scaffolds were coated with fibronectin according to standard
protocols [20]. SPCL were seeded with 500.000 OEC per scaffold with a base of
0.33 cm2 or, respectively, 250.000 primary osteoblasts and 250.000 OEC for the co-
cultures. The same cell culture medium, EGM-2 with 5% FCS; was used in both set
ups, monocultures or co-cultures according to the previously established protocols
[6] without additional supplementationwith angiogenic growth factors if not stated
otherwise.
2.4. Scanning electron microscopy of outgrowth endothelial cells on SPCL
Samples of SPCL seeded with OEC for scanning electron microscopy (SEM) were
treated as previously described [23] using standard procedures. In brief, samples
were fixed with 2% glutaraldehyde in 0.1 M cacodylate buffer for 30 min. Samples
were treated with 1% osmium tetroxide for 1 h, followed by dehydration using
increasing concentrations of acetone. Finally, samples were critically point dried and
sputtered with gold before analysis.
2.5. Immunofluorescent staining of cellular constructs
Outgrowth endothelial cells alone or in co-culture with osteoblastic cells on
SPCL were fixed using 2% paraformaldehyde (PFA). After washing with PBS cells
were permeabilized by 0.1% Triton-X, followed by the incubation with primary
antibodies, anti-human von Willebrand (vWF) (A0082 Dako, Hamburg, Germany,
diluted 1:8000), anti-human CD31 (M0823Dako, Hamburg, Germany, diluted
1:50), VE-Cadherin (C-26120 Transduction, Lexington, UK, diluted 1:100), in 1%
bovine serum albumin (BSA)/PBS for 40 min at room temperature. Then cells
were washed and labeled with the corresponding Alexa anti-mouse or anti-
rabbit conjugates, Alexa 488 anti-rabbit (A-21206), Alexa 488 anti-mouse (A-
11029), Alexa 546 anti-rabbit (A-11010), Alexa 546 anti-mouse (A-11030) (all
from Molecular Probes) diluted 1:1000 in 1% BSA/PBS for 40 min at room
temperature. Nuclear counterstaining was routinely performed using Hoechst or
PI (propidium iodide), respectively. Finally constructs were mounted with Gel-
mount (M01, Biomeda, Foster City, USA) and studied by confocal microscopy
using a LeicaTCS-NT.
2.6. Gene expression in monoculture of OEC or in co-cultures on SPCL
Total RNA was extracted from OEC grown for 1 week on SPCL scaffolds using
RNeasy Kit (Qiagen, Hilden, Germany). From the co-cultures RNAwas extracted after
two different time points after 1 and after 4 weeks of co-culturing. RNA isolationwas
performed including the treatment of isolated RNA with DNAse according to stan-
dard protocols to prevent impurities by genomic DNA. RNA was extracted directly
from the cells grown on the scaffolds by adding RNA-later buffer. 1 mg of RNA was
then transcribed into cDNA according to protocols from the Omniscript RT kit
(Qiagen).
2.7. Relative quantification (RQ) of gene expression by real time PCR
Quantitative real time PCR was performed with the use of Applied Biosystems
7300 Real Time PCR System (Applera Deutschland GmbH, Darmstadt, Germany). The
reaction composition was the following: 12.5 ml of 2" QuantiTect# SYBR! Green
PCR Master Mix, 2.5 ml of 10" QuantiTect# SYBR! Green Primer Assay (see Table 1),
5 ml of RNase-free water and 5 ml of cDNA pre-diluted 1:100 with RNase-free water.
All the reagents were provided by QIAGEN GmbH (Hilden, Germany). Each genewas
processed in triplicate. The specificity of PCR was assessed in a preliminary step on
the basis of dissociation curves. The relative quantification of gene expression was
assessed using the Applied Biosystems Sequence Detection Software v.1.2.2. The
housekeeping gene GAPDH was found to have the most consistent expression level
and was therefore chosen as an endogenous control for the experiments. The ratio
between the gene expression levels in OEC grown on SPCL versus tissue culture
plastic or in co-cultures of 1 or 4 weeks, respectively, was determined as indicated in
the individual graphs and the difference was considered to be significant, if p-values
obtained from the paired t-test were less than 0.05.
2.8. 3D-fibrin angiogenesis assays
OEC in monoculture were grown on the SPCL scaffolds for 1 week as
described above. To assess the response of OEC towards angiogenic stimulation
S. Fuchs et al. / Biomaterials 30 (2009) 526–534 527
constructs were embedded in fibrin gels as previously described [23] using the
in vitro Angiogenesis Assay Kit (ECM 630, Chemicon). After gelation fibrin gels
were covered with 1 ml of EGM-2 containing 10 ng/ml VEGF and the medium
was changed every second day. After 1 week the fibrin gels were fixed and
further processed for immunofluorescent staining as described in the previous
section.
2.9. Subcutaneous implantation of Matrigel! plugs and in vivo assessment of
cellular constructs of SPCL
This experiment was approved by the Committee on the Use of Live Animals in
Teaching and Research, Rheinland-Pfalz, Germany. Six male 6-week-old SCID mice
(Charles River Laboratories, Germany) were bred and kept under standard condi-
tions and provided with water ad libitum, artificial light and normal mouse pellet
(Laboratory Rodent Chow, Altromin, Germany) at the Laboratory Animal Unit,
Johannes Gutenberg University, Mainz, Germany. For Matrigel! plug experiments
OEC from 3 different donors were trypsinized and 3"106 OEC were resuspended in
400 ml Matrigel!. For the co-implantationwith pOB 1.5"106 and 1.5"106 OEC were
mixed in 400 ml Matrigel!. For each donor two animals were treated either with OEC
Matrigel! or OEC/pOB –Matrigel! suspension. Samples were kept on ice before the
cell containing Matrigel! was injected using a 20-gauge needle percutaneosly into
the subcutaneous region of the nude mice.
For the generation of cellular constructs SPCLwere seeded either with OEC alone
(500.000 cells per scaffold), or both cell types (pOB, OEC; 250.000 cells each). The
cellular constructs were prepared and pre-cultured for 1 week as previously
described. For some experiments cellular constructs on SPCL were embedded in
300–400 ml Matrigel!, before implantation and after gelation the constructs were
implanted as described below.
Eight male 6-week-old SCID mice (Charles River Laboratories, Germany) were
bred and kept under standard conditions and provided with water ad libitum,
artificial light and normal mouse pellet (Laboratory Rodent Chow, Altromin, Ger-
many). In vitro generated constructs were subcutaneously implanted in preformed
subcutaneous pockets of the subscapular region of the nude mice according to the
modified method of Hafemann [25]. The experimental group consisted of four
animals which were treated with SPCLþOEC from donor A or SPCLþOECþ pOB
from donor A, SPCLþOEC from donor B or SPCLþOECþ pOB from donor B. All
SPCL scaffolds of this group were embedded in Matrigel! (BD Biosciences, USA).
Two animals served as control for the the effects of Matrigel! and were implanted
with SPCLþOECþ pOB from either donor A or donor B, but these SPCL scaffolds
were not embedded in Matrigel!. As quality assurance measures for the in vivo
experiments as well as for the histomorphometrical analysis, one animal was
treated with SPCL embedded in Matrigel! (BD Biosciences, USA) and one animal
underwent a sham operation (i.e., a mock operation without biomaterial
implantation).
2.10. Histology and immunohistochemistry
After 14 days, mice were euthanized with an overdose of ketamine and xyla-
zine. Biomaterials were explanted together with the surrounding peri-implant
tissue, fixed in 4% formalin for 24 h, embedded in paraffin and prepared for
histological staining. Sections of 3 mm thickness were cut from the explanted tissue
and stained with Mayer’s haematoxylin and eosin (HE-staining). Von Willebrand
Factor antibodies (Dako, Sweden) detecting specifically human endothelial cells or
isolectin B4 (Vector Laboratories, Burlingame, CA) used as a murine endothelial cell
marker were visualized with diaminobenzidine (Vector Laboratories). For negative
controls, sections were treated similarly but omitting the primary antibody.
Histopathological evaluation was performed using a Nikon ECLIPSE 80i microscope
(Nikon, Japan) by two independent examiners blinded to the experimental
protocol. Microphotographs were taken using a Nikon DS-Fi1/Digital camera and
a digital sight control unit (Nikon, Japan) and prepared for further histomorpho-
logical analysis.
2.11. Histomorphometrical analysis
All images showing human cells (immunopositive for von Willebrand Factor)
were subjected to automatic quantification of the human cells using the S.CORE
Image Analysis System (S.CO LifeScience, Germany): In a first step all brown,
immunopositive structures were separated from the background with a threshold-
based approach. Then the brown elements were separated into areas with a weak-
diffuse staining and those with an intensive-condensed staining. All objects with
a weak-diffuse staining as well as very small objects with an intensive-condensed
staining were classified as ‘unspecific staining’. All other objects (bigger objects with
intensive-condensed staining) were classified as ‘specific staining’. The total area of
all objects with specific staining was determined as the parameter for the content of
human cells within the histological sections.
3. Results
3.1. Endothelial phenotype of outgrowth endothelial cells on SPCL
Outgrowth endothelial cells in monoculture adhered to the
single fibres of the SPCL scaffold material and formed an endo-
thelial cell layer. OEC seemed to retain the typical endothelial
phenotype on the SPCL fiber meshes which was demonstrated by
several methods such as scanning electron microscopy (Fig. 1A and
B). Immunofluorescent staining for endothelial markers such as
CD31 (Fig. 1D), VE-cadherin and vWF (data not shown) revealed the
formation of an interconnected endothelial cell layer. Cellular
contact molecules CD31 and VE-cadherin were situated along the
cellular contacts, comparable to HUVECs used as endothelial
controls (Fig. 1C). The morphology of the endothelial cell layers was
similar to controls which were run on tissue culture plastic. Similar
findings with regard to endothelial cells were observed using
additional methods investigating the expression of endothelial cell
markers such as CD31, VE-cadherin and vWF by Real Time PCR
(Fig. 1E). Relative gene expression of endothelial markers was
compared in cells grown on plastic (reference values set to 1) and
cells grown on the SPCL scaffold material by quantitative Real Time
PCR. The expression of CD31 and vWF was significantly reduced in
contrast to VE-cadherin, for which we only observed a slight
decrease with no statistical significance.
3.2. Response of outgrowth endothelial cells to angiogenic
stimulation
To assess the ability of OEC to respond to angiogenic stimuli and
to form microvessel-like structures OEC grown for 1 week on the
SPCLwere embedded in a fibrin gel and the growth factor VEGFwas
added to the cell culture medium as an angiogenic stimulus. By
immunostaining for the endothelial marker CD31 (depicted in
green, nuclear counterstaining in red) and confocal laser scanning
microscopy (Fig. 2A and B) we observed the angiogenic activation of
outgrowth endothelial cells leading to angiogenic sprout formation.
The angiogenic activation of OEC in more complex tissue engi-
neered constructs based on co-cultures with human primary
osteoblasts on SPCL fiber meshes was first assessed in vitro. Using
confocal microscopy co-cultures of OEC and pOB were investigated
after 1 week of co-culturing (Fig. 2C and D). OEC were identified by
staining for the endothelial marker CD31, depicted by green fluo-
rescence. Nuclear counterstaining was used to detect all cells,
including primary osteoblasts. OECwere embedded in a richmatrix
produced by primary osteoblasts and showed an elongated
morphology and an organization into microvessel-like structures
indicating an angiogenic activation by the co-culture process. The
maturity of those vascular sprouts increased with culture time (4
weeks, Fig. 2E and F). Nevertheless, as the formation of vascular
structures was already initiated after 1 week of co-culture, the
cellular constructs based on SPCL were implanted after 1 week of
pre-culture for further in vivo evaluation in terms of the angiogenic
potential of OEC.
Table 1
QuantiTect# SYBR! Green Primer Assays used in the experiment
Gene name Primer Assay name Catalogue number
PECAM Hs_PECAM1_1_SG QuantiTect
Primer Assay
QT00081172
VE-Cadherin Hs_CDH5_1_SG QuantiTect
Primer Assay
QT00013244
vWF Hs_VWF_1_SG QuantiTect
Primer Assay
QT00051975
Alkaline phosphatase Hs_ALPL_1_SG QuantiTect
Primer Assay
QT00012957
Osteocalcin Hs_BGLAP_1_SG QuantiTect
Primer Assay
QT00232771
GAPDH Hs_GAPDH_1_SG QuantiTect
Primer Assay
QT00079247
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3.3. Osteogenic potential of SPCL constructs
The potential of osteogenic differentiation of the SPCL
constructs under the applied culture conditions was assessed by
quantitative real time PCR for alkaline phosphatase and osteocalcin
comparing the expression rates after 1 and 4 weeks in the co-
culture (Fig. 3). In the investigated time frame we observed
a significant downregulation of alkaline phosphatase and a signifi-
cant increase in the expression of osteocalcin. (p-values$ 0.05).
3.4. Subcutaneous implantation of Matrigel plugs
In order to evaluate the angiogenic potential of OEC from
different donors in vivo and to assess the impact of the co-culture
with primary osteoblasts on OEC-derived vascular structures,
Matrigel! plugs containing either OEC alone or OEC and pOB were
implanted subcutaneously (Fig. 4A–E). Perfused microvessels of
mouse (Fig. 4A, ovals, von Willebrand factor-negative) or of human
origin (Fig. 4A, arrows, von Willebrand factor-positive) with
a diameter of up to 60 mmwere detected. In Fig. 4B–D the same area
is depicted in stainings with differential specifity. The human origin
of the vessels in this areawas confirmed by a positive staining using
human-specific van Willebrand antibodies (Fig. 4C) and the nega-
tive staining in a murine-specific isolectin staining (Fig. 4D).
Morphometric analysis was used to quantify vascular structures
comparing OEC implanted alone or co-implanted with pOB in
Matrigel! plugs. For all tested donors (n¼ 3) the same trend was
observed, indicating larger areas for human vascular structures in
Fig. 1. (A, B) Scanning electron microscopy of OEC grown on SPCL fiber mesh scaffolds (A, scale bar 200 mm; B, scale bar 20 mm) in different magnifications, showing coverage of the
fibres by endothelial cells of flattened morphology. (C, D) Immunofluorescence for endothelial marker CD31 depicted in green in HUVEC (C) and OEC (D) grown on SPCL scaffolding
material. Nuclear counterstaining in red, scale bar 150 mm. (E) Quantitative real time PCR for endothelial markers for OEC grown on tissue culture plastic or SPCL fiber meshes.
GAPDH was used as internal control. Expression levels on plastic were set as reference value (¼1). Relative quantification (RQ) of gene expression in OEC revealed statistically
significant downregulation of CD31 and vWF but not of VE-cadherin. * Indicate statistical significance$ p-value 0.05.
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co-implants of OEC and pOB compared to controls using OEC alone
(Fig. 4E).
3.5. Vascularization of SPCL contructs in vivo containing OEC
The SPCL fibres were well integrated into the surrounding peri-
implant tissue and were surrounded by both human (Fig. 5A;
arrows) and murine microvessels (Fig. 5A; circles). Vascular
structures in the peri-implant tissue were observed in both cases
with (Fig. 5) or without using Matrigel! (not shown) as embedding
matrix for the cellularized SPCL constructs. Nevertheless, embed-
ding of constructs in Matrigel! seemed to have a beneficial effect
on the formation of vascular structures in the peri-implant tissue
(compare also Fig. 6). The contribution of OEC to the vasculariza-
tion process was assessed using human-specific detection of
vascular structures or detection of vascular structures formed by
the host. Immunohistochemistry using the human-specific anti-
bodies for vWF (Fig. 5A and B) revealed vascular structures formed
by OEC mostly in close association with the SPCL fibres. These
vascular structures formed by OEC revealed lumina (Fig. 5A and B)
and contained erythrocytes as evidence of active perfusion. In
control staining, detecting vascular structures formed by mouse,
those vascular structures formed by OEC (Fig. 5B, red arrows)
where negative for the mouse-specific staining (Fig. 5C, blue
arrows). In addition, blood-filled chimeric vessels formed by both
human and mouse endothelial cells were observed (Fig. 5D, high-
lighted by ovals).
Histomorphometrical analysis was performed in addition to
assess the effect of Matrigel! as embeddingmaterial for the cellular
constructs, as well as to gain insight into the effects of co-cultures
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with pOB versus using OEC alone on the vascularization in the peri-
implant tissue (Fig. 6). Although there was a clear difference in the
contribution of the different OEC donors to the vascularization of
the SPCL constructs, embedding the cellular constructs inMatrigel!
led to a clear increase of vascular structures in the peri-implant
tissue. In addition, co-cultures consisting of OEC and primary
osteoblasts showed a positive effect of the vascularization
compared to the individual monocultures under the same experi-
mental settings.
4. Discussion
In this study we present experimental evidence that OEC,
a distinct populationof cellswith endothelial characteristics from the
peripheral blood, can contribute to a functional vascularization in
co-culture with pOB in a complex tissue engineered construct. These
constructs consisted of primary human osteoblasts and OEC
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Fig. 3. Real time PCR for osteogenic markers alkaline phosphatase and osteocalcin in
SPCL constructs consisting of endothelial cells and primary osteoblasts. Expression
levels after 1 week of culture were set as reference value (¼1) and compared to 4
weeks of culture indicating a significant downregulation of alkaline phosphatase (ALP)
and an increase in osetocalcin. * Indicate statistical significance$ p-value 0.05.
Fig. 4. OECs and pOBs or OEC alone (not depicted in histology) were embedded in Matrigel! and implanted subcutaneously into nude mouse for 14 days. (A) Histological sample
shows evidence for OEC (arrows) and murine endothelial cell (oval) derived microvessels in the Matrigel! (human-specific von Willebrand factor staining, 600"magnification). (B)
A higher resolution of a microvessel containing erythrocytes is shown (HE, 400" magnification). Its origin of human endothelial cells was proven by (C) a positive human-specific
von Willebrand factor staining, 400" magnification and (D) by a negative murine-specific endothelial cell marker (isolectin staining, 400" magnification). Scale bars A–D, 100 mm.
(E) Morphometric quantification of the vascular area formed by OEC for 3 different donors implanted either alone or co-implanted with primary osteoblasts in Matrigel! plugs.
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pre-cultured on SPCL fiber mesh scaffolds. Prevascular structures
were induced by co-culturing OEC with primary osteoblasts on SPCL
scaffolds, which were achieved without additional supplementation
of culture mediumwith angiogenic growth factors. Co-implantation
ofOEC and pOB inMatrigel! plugs showed the contribution of OEC to
perfused vascular structures and a beneficial effect on the vascular
potential of OEC by co-implantation with pOB, although the reason
for this observation deserves further investigation. Similar findings
were also observed for co-cultures on SPCL. In cellular constructs
consisting of OEC and primary osteoblasts on SPCL implanted
subcutaneously into a nude mouse model, OEC formed vascular
structures closely associated with the scaffold material and
embedded in a rich extracellular matrix produced by the primary
osteoblasts. Vascular structures formed by OEC were functionally
connected to the vascular supply of the host as indicated by eryth-
rocytes detected in luminal vascular structures. Additional experi-
ments investigating the vascularization process in a time course
experiment are currently under way to gain more insight into the
dynamics of the vascularization process.
To some extent microvessel-like structures were already
induced in vitro by a short pre-culturing phase in co-culture with
primary osteoblasts. Such co-culture techniques seem to promote
an angiogenic activation of OEC as indicated by our previous study
inducing prevascular structures with definitive vascular lumina
[6]. Similar findings were also observed for adult microvascular
endothelial cells co-cultured with osteoblasts on silk fibroin scaf-
folds, where the organization of endothelial cells into vascular
structures clearly increased with progressing culture time [5]. In
the present study, morphometric quantification of the vessel area
suggests that the co-culturing or co-implantation process with
primary osteoblasts also has a beneficial influence on the forma-
tion of vascular structures in vivo. These observations are in
accordance with several reports indicating a beneficial effect of co-
cultures consisting of endothelial cells with several other cell
types for the vascularization process and the formation of durable
blood vessels in vivo [19,26]. Several mechanisms such as
embedding endothelial cells into a rich extracellular matrix or
angiogenic activation of endothelial cells by paracrine factors are
probably responsible for those beneficial effects. Furthermore, co-
cultures seem to support the stabilization of vessels by providing
mural cells, which are essential, especially for the long term
stabilization of newly formed blood vessels [16]. Although these
studies have demonstrated the general potential of OEC to
contribute to the vascularization process in vivo, these studies also
emphasized that the therapeutical relevance of these cells criti-
cally depends on the experimental setting such as co-implantation
with other cell types. Likewise, OEC revealed an altered vasculo-
genic potential in an endothelial spheroid-based implantation
model in vivo compared to HUVEC (Finkenzeller et al., Cell
Proliferation accepted) although the angiogenic activity of HUVEC
and OEC in vitro were similar. Whether such differences in the
vasculogenic potential in pure endothelial approaches derive from
differences at the molecular level between mature or progenitor
derived cells or from the macro- or microvascular character of
HUVEC or OEC, respectively, still needs further investigation.
Interestingly, recent studies comparing Affymetrix microarray data
indicated that blood outgrowth endothelial cells were different
from macrovascular cells (HUVEC), whereas they shared similari-
ties with microvascular cells or may be classified as an individual
subtype of the endothelial cell [27]. This is also in accordance with
our observations from co-culture experiments with osteoblasts,
comparing HUVEC and OEC [6].
Furthermore, embedding of cellular constructs based on SPCL
into Matrigel! was highly supportive of the formation of vascular
structures in the peri-implant tissue. Matrigel! might serve as
a kind of stabilizing matrix for the cellular constructs and has been
used in several studies to assess the angiogenic potential of OEC.
Although the relevance of Matrigel! is limited in clinical applica-
tions, the present study suggests that embedding of cellular
constructs into gels such as Matrigel! or hydrogels might be
beneficial for the vascularization process of tissue engineered
constructs. Moreover, on account of the possibility of bio-
functionalization of those matrices, the tailored physico-chemical
properties of such embedding matrices might be useful to control
the migratory activity of the endothelial cells and to stabilize
vascular structures.
The present study was specifically performed to answer the
question of whether OEC could add to the vascularization of tissue
engineered bone constructs based on 3D SPCL scaffolds and to
A
100 µM
SPCL
D
100 µM
SPCL
B
Human specific
100 µM
100 µm
mouse specific
C
100 µM
100 µm
100 µm
Fig. 5. The contribution of co-cultures consisting of pOB and OEC on SPCL embedded
in Matrigel! to the vascularization of the peri-implant tissue of the nude mouse. (A)
After implantation of cellular constructs, histological samples from the peri-implant
tissue show evidence for contribution of OECs (arrows) and murine endothelial cells
(ovals) to the formation of blood-filled vessels containing erythrocytes (human-
specific vWF-staining, Dako, Sweden, 100" magnification). (B) Human cell-derived
microvessels both in cross and in longitudinal section (red arrows), (human-specific
vWF-staining, Dako, Sweden, 400" magnification) remain unstained in their corre-
sponding tissue segment after isolectin-B4 (C) staining for murine structures (blue
arrows), (Isolectin B4 (Vector Laboratories, Burlingame, CA), 400" magnification). (D)
In some vessels of the peri-implant tissue of nude mice treated with OECþ pOB
co-culture chimaeric vessels, containing both human and murine endothelial cells
were observed (red ovals), (human-specific vWF-staining, Dako, Sweden, 400"
magnification) pure murine vessels (blue ovals).
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determine the effect of the co-culture with pOB on the angiogenic
activity of OEC. On the other hand, it is well known that osteo-
genesis itself is dependent on a functional interaction of endothelial
cells and osteoblasts. Initial characterization of complex SPCL
scaffolds by quantitative real time PCR indicated the upregulation
of the late osteoblastic marker osteocalcin and a decrease in the
early marker alkaline phosphatase with progressing pre-culture
time (Fig. 3). These data indicate the progressing differentiation of
osteoblastic cells in complex SPCL constructs under the culture
conditions mainly tailored for OEC. More detailed investigation of
the dynamics of endothelial and osteogenic markers, matrix
components and vessel formation within complex constructs in
vitro is also provided in an additional study based on silk fibroin
scaffolds (manuscript submitted), whereas the present paper
focuses on the beneficial effect of the co-cultures on the vascular-
ization process by OEC. Nevertheless, the in vivo bone formation of
such constructs needs to be investigated in further studies using
additional models suitable for monitoring bone formation.
5. Conclusions
This manuscript describes the contribution of human OEC,
a distinct subpopulation within EPC cultures from the peripheral
blood, to the vascularization of a bone tissue construct in a nude
mouse model in vivo. Co-cultures or co-implantation of OEC with
pOB exerted a beneficial effect on the vascularization process by
OEC. The regeneration and repair of highly vascularized tissues and
larger tissue defects such as in bone might profit from the use of
OEC as autologous cell sources. Our findings might have an impact
on further developments of prevascularized tissues for bone based
on endothelial progenitor cells.
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Appendix
Figures with essential colour discrimination. Certain figures in
this article, in particular parts of Figures 1,2,4 and 5 are difficult to
interpret in black and white. The full colour images can be found in
the on-line version, at doi: 10.1016/j.biomaterials.2008.09.058.
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